BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25974314)

  • 1. Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land?
    Blum K; Thanos PK; Badgaiyan RD; Febo M; Oscar-Berman M; Fratantonio J; Demotrovics Z; Gold MS
    Expert Opin Biol Ther; 2015 Jul; 15(7):973-85. PubMed ID: 25974314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS).
    Blum K; Oscar-Berman M; Demetrovics Z; Barh D; Gold MS
    Mol Neurobiol; 2014 Dec; 50(3):765-96. PubMed ID: 24878765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric.
    Blum K; Febo M; McLaughlin T; Cronjé FJ; Han D; Gold SM
    J Behav Addict; 2014 Sep; 3(3):149-56. PubMed ID: 25317338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.
    Blum K; Gold MS
    Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry.
    Gold MS; Badgaiyan RD; Blum K
    Psychiatr Clin North Am; 2015 Sep; 38(3):419-62. PubMed ID: 26300032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
    Blum K; Febo M; Fried L; Li M; Dushaj K; Braverman ER; McLaughlin T; Steinberg B; Badgaiyan RD
    Subst Use Misuse; 2017 Mar; 52(4):535-547. PubMed ID: 28033474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms.
    Blum K; Simpatico T; Badgaiyan RD; Demetrovics Z; Fratantonio J; Agan G; Febo M; Gold MS
    J Reward Defic Syndr; 2015; 1(2):75-80. PubMed ID: 27617300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine Genetics and Function in Food and Substance Abuse.
    Blum K; Oscar-Berman M; Barh D; Giordano J; Gold M
    J Genet Syndr Gene Ther; 2013 Feb; 4(121):. PubMed ID: 23543775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurogenetic Impairments of Brain Reward Circuitry Links to Reward Deficiency Syndrome (RDS): Potential Nutrigenomic Induced Dopaminergic Activation.
    Blum K; Oscar-Berman M; Giordano J; Downs B; Simpatico T; Han D; Femino J
    J Genet Syndr Gene Ther; 2012 Oct; 3(4):. PubMed ID: 23264886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis.
    Blum K; Chen TJ; Meshkin B; Waite RL; Downs BW; Blum SH; Mengucci JF; Arcuri V; Braverman ER; Palomo T
    Med Hypotheses; 2007; 69(5):1054-60. PubMed ID: 17467918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?
    Blum K; Febo M; Thanos PK; Baron D; Fratantonio J; Gold M
    Mol Neurobiol; 2015 Dec; 52(3):1862-1869. PubMed ID: 25750061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape.
    Blum K; Febo M; Badgaiyan RD; Demetrovics Z; Simpatico T; Fahlke C; M OB; Li M; Dushaj K; Gold MS
    Curr Neuropharmacol; 2017; 15(1):184-194. PubMed ID: 27174576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: proposing an addiction candidate gene panel map.
    Chen TJ; Blum K; Chen AL; Bowirrat A; Downs WB; Madigan MA; Waite RL; Bailey JA; Kerner M; Yeldandi S; Majmundar N; Giordano J; Morse S; Miller D; Fornari F; Braverman ER
    J Psychoactive Drugs; 2011; 43(2):108-27. PubMed ID: 21858957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms.
    Blum K; Oscar-Berman M; Stuller E; Miller D; Giordano J; Morse S; McCormick L; Downs WB; Waite RL; Barh D; Neal D; Braverman ER; Lohmann R; Borsten J; Hauser M; Han D; Liu Y; Helman M; Simpatico T
    J Addict Res Ther; 2012 Nov; 3(5):139. PubMed ID: 23926462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systems medicine research approach for studying alcohol addiction.
    Spanagel R; Durstewitz D; Hansson A; Heinz A; Kiefer F; Köhr G; Matthäus F; Nöthen MM; Noori HR; Obermayer K; Rietschel M; Schloss P; Scholz H; Schumann G; Smolka M; Sommer W; Vengeliene V; Walter H; Wurst W; Zimmermann US; ; Stringer S; Smits Y; Derks EM
    Addict Biol; 2013 Nov; 18(6):883-96. PubMed ID: 24283978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics.
    Blum K; Badgaiyan RD; Gold MS
    Cureus; 2015 Oct; 7(10):e348. PubMed ID: 26623203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?
    Blum K; Dennen CA; Elman I; Bowirrat A; Thanos PK; Badgaiyan RD; Downs BW; Bagchi D; Baron D; Braverman ER; Gupta A; Green R; McLaughlin T; Barh D; Gold MS
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curious cases: Altered dose-response relationships in addiction genetics.
    Uhl GR; Drgonova J; Hall FS
    Pharmacol Ther; 2014 Mar; 141(3):335-46. PubMed ID: 24189489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions.
    Blum K; Bowirrat A; Braverman ER; Baron D; Cadet JL; Kazmi S; Elman I; Thanos PK; Badgaiyan RD; Downs WB; Bagchi D; Llanos-Gomez L; Gold MS
    Int J Environ Res Public Health; 2021 Nov; 18(21):. PubMed ID: 34770047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Genetic Testing in Reward Deficiency Syndrome (RDS): Facts and Fiction.
    Blum K; Badgaiyan RD; Agan G; Fratantonio J; Simpatico T; Febo M; Haberstick BC; Smolen A; Gold MS
    J Reward Defic Syndr; 2015; 1(1):65-68. PubMed ID: 26052557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.